We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Intuitive Surgical Inc (ISRG) Com Stk USD

Sell:$397.88 Buy:$398.00 Change: $12.30 (3.19%)
Market closed |  Prices as at close on 1 March 2024 | Switch to live prices |
Change: $12.30 (3.19%)
Market closed |  Prices as at close on 1 March 2024 | Switch to live prices |
Change: $12.30 (3.19%)
Market closed |  Prices as at close on 1 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.

Contact details

1020 Kifer Road
United States
+1 (408) 5232100

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$136.21 billion
Shares in issue:
352.33 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • David Rosa
  • Gary Guthart
    Chief Executive Officer, Director
  • Jamie Samath
    Chief Financial Officer, Senior Vice President
  • Michele Dimartino
    Chief Human Resource Officer, Senior Vice President
  • Myriam Curet
    Executive Vice President, Chief Medical Officer
  • Bob DeSantis
    Executive Vice President and Chief Product Officer
  • Marshall Mohr
    Executive Vice President - Global Business Services
  • Gary Loeb
    Senior Vice President, Chief Compliance Officer, General Counsel
  • Henry Charlton
    Senior Vice President, Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.